New Alaska Supreme Court Ruling Regarding Ex Parte
New ruling in Alaska restricts disclosure of patient information related to litigation. For decades, Alaska has allowed informal methods of “discovery” (sharing of information) during litigation, including private discussions between defense attorneys and the plaintiff’s treating physicians. These “ex parte” communications were encouraged by the Alaska Supreme Court, as they facilitated early evaluation and settlement of cases, with a resulting decrease in litigation costs. However, a new ruling by the Court on June 22, 2018, determined that a cultural shift in views on medical privacy warranted overruling this practice. In Harrold-Jones vs. Drury, et al., the Court held that “absent...
As of October 2, 2018, all providers practicing in California must check the Controlled Substance Utilization Review and Evaluation System (CURES) database before prescribing certain medications, including opioid pain medications. Physicians and advanced practice providers who prescribe controlled substances already must be registered with CURES 2.0, according to state law. California Health and Safety Code Section 11165.1 requires health care practitioners authorized to prescribe, order, administer, furnish, or dispense scheduled controlled substances to submit a CURES registration application to the Department of Justice before July 1, 2016, or upon receipt of a DEA registration. Senate Bill 482, which was signed...
Hawai’i Providers: Mandatory Opioid Prescription Requirements under Act 66
MIEC’s member providers in Hawai'i who prescribe opioid pain medications should be aware of a new state law which just went into effect this month. This new law imposes more stringent requirements around chronic pain management, patients who are also taking anti-anxiety medication, and/or patient who are on large dosages of opioids. Specific elements of the law are discussed below. Under Hawai'i Act 66 (17), Relating to Heath, as of July 1, 2018, all providers authorized to prescribe opioids in Hawai'i must adopt a written policy that includes the execution of a written informed consent document when prescribing opioids to...
The federal government has published its final regulations implementing the “Health Information Technology for Economic and Clinical Health (HITECH) Act,” which modified and expanded the existing HIPAA Privacy and Security Rules, and other statutes. An interim set of guidelines has been in place since 2010, and MIEC provided guidance at that time on complying with the interim rule; therefore, you may have already implemented many of the required changes (such as data-breach notification requirements) into your HIPAA policies and procedures. The following summarizes key points from the Interim and Final Rules, and includes action items for updating your HIPAA policies...
From Underwriting: Liability Risks of Indemnification Clauses
By: Susan F. Halman, Esq. from Selvin, Wraith, Halman LLP in Oakland, CA An indemnification clause in a professional service agreement ("PSA") can create onerous and uninsured financial exposures when it requires the physician to assume liability for risks outside of their control. Before signing a PSA that contains an indemnification clause, it is important to understand the breadth of the parties' respective indemnity obligations, and the extent to which you will be assuming a duty to defend and indemnify third parties for liability exposures that are not insured by your MIEC policy. An indemnification clause operates to allocate legal...